Products & Services · Total Revenue

QALSODY — Total Revenue

Biogen QALSODY — Total Revenue increased by 30.0% to $32.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 109.7%, from $15.50M to $32.50M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful market penetration and growing demand for the therapy, while a decrease may signal competitive pressure or loss of market share.

Detailed definition

This metric represents the total gross revenue generated from the sale of a specific pharmaceutical product or therapeut...

Peer comparison

Comparable to product-specific revenue lines reported by other biopharmaceutical companies for their key commercialized assets.

Metric ID: biib_segment_qalsody_total_revenue

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$900.00K$1.70M$3.30M$4.60M$5.00M$11.10M$11.70M$15.50M$20.00M$26.40M$25.00M$32.50M
QoQ Change+88.9%+94.1%+39.4%+8.7%+122.0%+5.4%+32.5%+29.0%+32.0%-5.3%+30.0%
YoY Change+455.6%+552.9%+254.5%+237.0%+300.0%+137.8%+113.7%+109.7%
Range$0.00$32.50M
Avg YoY Growth+270.1%
Median YoY Growth+245.8%

Frequently Asked Questions

What is Biogen's qalsody — total revenue?
Biogen (BIIB) reported qalsody — total revenue of $32.50M in Q1 2026.
How has Biogen's qalsody — total revenue changed year-over-year?
Biogen's qalsody — total revenue increased by 109.7% year-over-year, from $15.50M to $32.50M.
What does qalsody — total revenue mean?
The total sales revenue generated by a specific pharmaceutical product.